Literature DB >> 2604387

Intraventricular infusion of Dopamine in Parkinson's disease.

M K Horne1, E G Butler, B S Gilligan, J Wodak, R J Stark, G A Brazenor.   

Abstract

A patient with severe end-stage Parkinson's disease and troublesome fluctuations in motor function was treated with a long-term intraventricular infusion of dopamine. There was modest improvement in speech and mentation and there was smoother control of motor symptoms that was superior to that achieved by conventional oral medications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2604387     DOI: 10.1002/ana.410260620

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

Review 1.  Improving the Delivery of Levodopa in Parkinson's Disease: A Review of Approved and Emerging Therapies.

Authors:  Daniele Urso; K Ray Chaudhuri; Mubasher A Qamar; Peter Jenner
Journal:  CNS Drugs       Date:  2020-11-04       Impact factor: 5.749

2.  Intracerebroventricular dopamine for Parkinson's disease.

Authors:  David Devos; Jean-Christophe Devedjian; Caroline Moreau
Journal:  Oncotarget       Date:  2017-07-11

Review 3.  Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia.

Authors:  Andrea Fabbrini; Andrea Guerra
Journal:  J Exp Pharmacol       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.